Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | HLA-DOA |
| Upstream (Parents) |
|---|
| (<<) ALPPL2 → HLA-DOA |
| (<<) BBC3 → HLA-DOA |
| (<<) BCL2L1 → HLA-DOA |
| (<<) BCL3 → HLA-DOA |
| (<<) CARD9 → HLA-DOA |
| (<<) CDH22 → HLA-DOA |
| (<<) CHST10 → HLA-DOA |
| (<<) CRK → HLA-DOA |
| (<<) CYP1A1 → HLA-DOA |
| (<<) CYP1A2 → HLA-DOA |
| (<<) DSCAM → HLA-DOA |
| (<<) EP300 → HLA-DOA |
| (<<) EPHB6 → HLA-DOA |
| (<<) GALR3 → HLA-DOA |
| (<<) ID1 → HLA-DOA |
| (<<) INPP5D → HLA-DOA |
| (<<) INPPL1 → HLA-DOA |
| (<<) KHDRBS1 → HLA-DOA |
| (<<) MYL5 → HLA-DOA |
| (<<) NFKB1 → HLA-DOA |
| (<<) NFKBIA → HLA-DOA |
| (<<) PIM1 → HLA-DOA |
| (<<) POP1 → HLA-DOA |
| (<<) PRKCI → HLA-DOA |
| (<<) PRPF4B → HLA-DOA |
| (<<) PRR5 → HLA-DOA |
| (<<) PTMS → HLA-DOA |
| (<<) RBL2 → HLA-DOA |
| (<<) RCBTB1 → HLA-DOA |
| (<<) RPL35 → HLA-DOA |
| (<<) RXRA → HLA-DOA |
| (<<) RXRB → HLA-DOA |
| (<<) SGSH → HLA-DOA |
| (<<) SLC25A37 → HLA-DOA |
| (<<) SYN1 → HLA-DOA |
| (<<) TSC22D1 → HLA-DOA |
| (<<) TUBA1B → HLA-DOA |
| (<<) TXNIP → HLA-DOA |
| (<<) UBE2L6 → HLA-DOA |
| Downstream (Children) |
|---|
| HLA-DOA → ELF2 (>>) |
| HLA-DOA → FER1L4 (>>) |
| HLA-DOA → ME1 (>>) |
| HLA-DOA → MMP28 (>>) |
| HLA-DOA → NRG1 (>>) |
| HLA-DOA → T (>>) |
| HLA-DOA → VANGL1 (>>) |
| HLA-DOA → ZFP36L1 (>>) |
